File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1007/s11095-011-0526-2
- Scopus: eid_2-s2.0-83455206025
- PMID: 21773853
- WOS: WOS:000297710200007
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: MicroRNAs and cancer therapeutics
Title | MicroRNAs and cancer therapeutics |
---|---|
Authors | |
Keywords | HTLV-1 leukemia microRNA nanoparticles oncomiRs |
Issue Date | 2011 |
Publisher | Springer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0724-8741 |
Citation | Pharmaceutical Research, 2011, v. 28 n. 12, p. 3043-3049 How to Cite? |
Abstract | MicroRNAs (miRNAs) are small physiological non-coding RNAs that regulate gene expression through an RNA interference (RNAi) mechanism. The expression of miRNAs is tightly controlled both spatially and temporally. Aberrant miRNA expression has been correlated with various cancers. Recent findings suggest that some miRNAs can function as tumor suppressors or oncogenes. In model experiments, the cancer phenotype of some cells can be reverted to normal when the cells are treated with miRNA mimics or inhibitors. Here, we discuss in brief the potential utility of miRNA-based cancer therapy as well as the current limitations thwarting their useful clinical application. © 2011 Springer Science + Business Media, LLC (outside the USA). |
Persistent Identifier | http://hdl.handle.net/10722/157660 |
ISSN | 2023 Impact Factor: 3.5 2023 SCImago Journal Rankings: 0.707 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yeung, ML | en_US |
dc.contributor.author | Jeang, KT | en_US |
dc.date.accessioned | 2012-08-08T08:52:01Z | - |
dc.date.available | 2012-08-08T08:52:01Z | - |
dc.date.issued | 2011 | en_US |
dc.identifier.citation | Pharmaceutical Research, 2011, v. 28 n. 12, p. 3043-3049 | en_US |
dc.identifier.issn | 0724-8741 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/157660 | - |
dc.description.abstract | MicroRNAs (miRNAs) are small physiological non-coding RNAs that regulate gene expression through an RNA interference (RNAi) mechanism. The expression of miRNAs is tightly controlled both spatially and temporally. Aberrant miRNA expression has been correlated with various cancers. Recent findings suggest that some miRNAs can function as tumor suppressors or oncogenes. In model experiments, the cancer phenotype of some cells can be reverted to normal when the cells are treated with miRNA mimics or inhibitors. Here, we discuss in brief the potential utility of miRNA-based cancer therapy as well as the current limitations thwarting their useful clinical application. © 2011 Springer Science + Business Media, LLC (outside the USA). | en_US |
dc.language | eng | en_US |
dc.publisher | Springer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0724-8741 | en_US |
dc.relation.ispartof | Pharmaceutical Research | en_US |
dc.subject | HTLV-1 | - |
dc.subject | leukemia | - |
dc.subject | microRNA | - |
dc.subject | nanoparticles | - |
dc.subject | oncomiRs | - |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Gene Expression Regulation, Neoplastic | en_US |
dc.subject.mesh | Gene Therapy | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Micrornas - Administration & Dosage - Genetics - Therapeutic Use | en_US |
dc.subject.mesh | Nanoparticles - Chemistry | en_US |
dc.subject.mesh | Neoplasms - Genetics - Therapy | en_US |
dc.subject.mesh | Oncogenes - Genetics | en_US |
dc.subject.mesh | Rna Interference | en_US |
dc.title | MicroRNAs and cancer therapeutics | en_US |
dc.type | Article | en_US |
dc.identifier.email | Yeung, ML:pmlyeung@hku.hk | en_US |
dc.identifier.authority | Yeung, ML=rp01402 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1007/s11095-011-0526-2 | en_US |
dc.identifier.pmid | 21773853 | - |
dc.identifier.scopus | eid_2-s2.0-83455206025 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-83455206025&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 28 | en_US |
dc.identifier.issue | 12 | en_US |
dc.identifier.spage | 3043 | en_US |
dc.identifier.epage | 3049 | en_US |
dc.identifier.isi | WOS:000297710200007 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Yeung, ML=8350940900 | en_US |
dc.identifier.scopusauthorid | Jeang, KT=7004824803 | en_US |
dc.identifier.citeulike | 9589792 | - |
dc.identifier.issnl | 0724-8741 | - |